Jack Hildick-Smith | Stern IR |
Derek Chalmers | President and CEO |
Rick Makara | VP and Head, Accounting |
Chris Howerton | Jefferies |
David Amsellem | Piper Sandler |
Annabel Samimy | Stifel |
Jason Gerberry | Bank of America |
Alan Carr | Needham & Company |
Good afternoon and welcome to Cara Therapeutics' Second Quarter 2020 Financial Results Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Cara's request. I would now like to turn the call over to the Cara team.